A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus

Human Molecular Genetics

Volumn 18, Issue 3, 2008, Pages 569-579

  Orrú, Valeria ^a   Tsai, Sophia J ^b   Rueda, Blanca ^c   Fiorillo, Edoardo ^a   Stanford, Stephanie M ^a   Dasgupta, Jhimli ^b   Hartiala, Jaana ^a   Zhao, Lei ^a   Ortego Centeno, Norberto ^d   D'Alfonso, Sandra ^e   Arnett, Frank C ^f,q   Wu, Hui ^g,q   Gonzalez Gay, Miguel A ^h,q   Tsao, Betty P ^g,q   Pons Estel, Bernardo ^i,q   Alarcon Riquelme, Marta E ^j,q   He, Yantao ^k,q   Zhang, Zhong Yin ^k,q   Allayee, Hooman ^a,q   Chen, Xiaojiang S ^b,q   Martin, Javier ^c,q   Bottini, Nunzio ^a,q   Danieli, Giovanna ^l   Galeazzi, Mauro ^m   Sabbadini, Maria Grazia ⁿ   Migliaresi, Sergio ^o   Sebastiani, Gian Domenico ^p   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^d HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h HOSPITAL XERAL CALDE   (Spain)

ⁱ Sanatorio Parque   (Argentina)

^j UPPSALA UNIVERSITY   (Sweden)

^k INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^m UNIVERSITY OF SIENA   (Italy)

ⁿ SAN RAFFAELE HOSPITAL   (Italy)

^o SECOND UNIVERSITY OF NAPLES   (Italy)

^p SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^q NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; GLUTAMINE; GLYCINE; LYMPHOID TYROSINE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OKT 3; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE FUNCTION; GENE LOSS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; RISK REDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 58849120030     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn363     Document Type: Article

References (30)

1. Cloutier, J.F. and Veillette, A. (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med., 189, 111-121.
2. Wu, J., Katrekar, A., Honigberg, L.A., Smith, A.M., Conn, M.T., Tang, J., Jeffery, D., Mortara, K., Sampang, J., Williams, S.R. et al. (2006) Identification of substrates of human protein-tyrosine phosphatase PTPN22. J. Biol. Chem., 281, 11002-11010.
3. Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J., Meloni, G.F., Lucarelli, P., Pellecchia, M. et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet., 36 337-338.
4. Begovich, A.B., Carlton, V.E., Honigberg, L.A., Schrodi, S.J., Chokkalingam, A.P., Alexander, H.C., Ardlie, K.G., Huang, Q., Smith, A.M., Spoerke, J.M. et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet., 75 330-337.
5. Kyogoku, C., Langefeld, C.D., Ortmann, W.A., Lee, A., Selby, S., Carlton, V.E., Chang, M., Ramos, P., Baechler, E.C., Batliwalla, F.M. et al. (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet., 75, 504-507.
6. Lee, Y.H., Rho, Y.H., Choi, S.J., Ji, J.D., Song, G.G., Nath, S.K. and Harley, J.B. (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford), 46, 49-56.
7. Vang, T., Congia, M., Macis, M.D., Musumeci, L., Orru, V., Zavattari, P., Nika, K., Tautz, L., Tasken, K., Cucca, F. et al. (2005) Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet., 37, 1317-1319.
8. Rieck, M., Arechiga, A., Onengut-Gumuscu, S., Greenbaum, C., Concannon, P. and Buckner, J.H. (2007) Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol., 179, 4704-4710.
9. Siggs, O.M., Miosge, L.A., Yates, A.L., Kucharska, E.M., Sheahan, D., Brdicka, T., Weiss, A., Liston, A. and Goodnow, C.C. (2007) Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity, 27, 912-926.
10. Yu, X., Sun, J.P., He, Y., Guo, X., Liu, S., Zhou, B., Hudmon, A. and Zhang, Z.Y. (2007) Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc. Natl Acad. Sci. USA, 104, 19767-19772.
11. Carlton, V.E., Hu, X., Chokkalingam, A.P., Schrodi, S.J., Brandon, R., Alexander, H.C., Chang, M., Catanese, J.J., Leong, D.U., Ardlie, K.G. et al. (2005) PTPN22 genetic variation: Evidence for multiple variants associated with rheumatoid arthritis. Am. J. Hum. Genet., 77, 567-581.
12. Zoledziewska, M., Perra, C., Orru, V., Moi, L., Frongia, P., Congia, M., Bottini, N. and Cucca, F. (2008) Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes. Diabetes 57, 229-234.
13. Gregersen, P.K., Lee, H.S., Batliwalla, F. and Begovich, A.B. (2006) PTPN22: Setting thresholds for autoimmunity. Semin. Immunol., 18, 214-223.
14. McPartland, J.M., Norris, R.W. and Kilpatrick, C.W. (2007) Tempo and mode in the endocannaboinoid system. J. Mol. Evol., 65, 267-276.
15. Chatenoud, L. (2006) CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic. Int. Rev. Immunol., 25, 215-233.
16. Liggett, S.B., Cresci, S., Kelly, R.J., Syed, F.M., Matkovich, S.J., Hahn, H.S., Diwan, A., Martini, J.S., Sparks, L., Parekh, R.R. et al. (2008) A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat. Med., 14, 510-517.
17. Skinningsrud, B., Husebye, E.S., Gervin, K., Lovas, K., Blomhoff, A., Wolff, A.B., Kemp, E.H., Egeland, T. and Undlien, D.E. (2008) Mutation screening of PTPN22: Association of the 1858T-allele with Addison's disease. Eur. J. Hum. Genet., 8, 977-982.
18. Kozyrev, S.V., Lewen, S., Reddy, P.M., Pons-Estel, B., Witte, T., Junker, P., Laustrup, H., Gutierrez, C., Suarez, A., Francisca Gonzalez-Escribano, M. et al. (2007) Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum., 56, 1234-1241.
19. Kozyrev, S.V., Abelson, A.K., Wojcik, J., Zaghlool, A., Linga Reddy, M.V., Sanchez, E., Gunnarsson, I., Svenungsson, E., Sturfelt, G., Jonsen, A. et al. (2008) Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40, 211-216.
20. Wu, H., Boackle, S.A., Hanvivadhanakul, P., Ulgiati, D., Grossman, J.M., Lee, Y., Shen, N., Abraham, L.J., Mercer, T.R., Park, E. et al. (2007) Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc. Natl Acad. Sci. USA, 104, 3961-3966.
21. Arnett, F.C., Thiagarajan, P., Ahn, C. and Reveille, J.D. (1999) Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis Rheum., 42, 268-274.
22. Hochberg, M.C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40, 1725.
23. Saito, K., Williams, S., Bulankina, A., Honing, S. and Mustelin, T. (2007) Association of protein-tyrosine phosphatase MEG2 via its Sec14p homology domain with vesicle-trafficking proteins. J. Biol. Chem., 282, 15170-15178.
24. Shaw, J.P., Utz, P.J., Durand, D.B., Toole, J.J., Emmel, E.A. and Crabtree, G.R. (1988) Identification of a putative regulator of early T cell activation genes. Science, 241, 202-205.
25. Weiss, A. and Stobo, J.D. (1984) Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J. Exp. Med., 160, 1284-1299.
26. Overton, W.R. (1988) Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry, 9, 619-626.
27. Kung, P., Goldstein, G., Reinherz, E.L. and Schlossman, S.F. (1979) Monoclonal antibodies defining distinctive human T cell surface antigens. Science, 206, 347-349.
28. Bardsley, W.G., Leff, P., Kavanagh, J. and Waight, R.D. (1980) Deviations from Michaelis-Menten kinetics. The possibility of complicated curves for simple kinetic schemes and the computer fitting of experimental data for acetylcholinesterase, acid phosphatase, adenosine deaminase, arylsulphatase, benzylamine oxidase, chymotrypsin, fumarase, galactose dehydrogenase, beta-galactosidase, lactate dehydrogenase, peroxidase and xanthine oxidase. Biochem. J., 187, 739-765.
29. Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 22, 4673-4680.
30. Taylor, J.R. (1997) An introduction to error analysis. In University Science Books, 2nd edn.